Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women

Clinical and Diagnostic Laboratory Immunology

Volumn 4, Issue 2, 1997, Pages 122-126

  Viscidi, Raphael P ^a,d   Kotloff, Karen L ^b   Clayman, Barbara ^a   Russ, Karin ^b   Shapiro, Sharon ^b   Shah, Keerti V ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS INFECTION; WART VIRUS;

EID: 0030966145     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.4.2.122-126.1997     Document Type: Article

References (33)

1. Burkett, B. J., C. M. Peterson, L. M. Birch, C. Brennan, M. L. Nickols, B. E. Ward, and C. P. Crum. 1992. The relationship between contraceptives, sexual practices, and cervical human papillomavirus infection among a college population. J. Clin. Epidemiol. 11:1295-1302.
2. Carter, J. J., M. B. Hagensee, S. K. Lee, B. McKnight, L. A. Koutsky, and D. A. Galloway. 1994. Use of HPV 1 capsids produced by recombinant vaccinia viruses in an ELISA to detect serum antibodies in people with foot warts. Virology 199:284-291.
3. Carter, J. J., G. C. Wipf, M. E. Hagensee, B. McKnight, L. A. Habel, S. K. Lee, J. Kuypers, N. Kiviat, J. Daling, L. Koutsky, D. H. Watts, K. K. Holmes, and D. A. Galloway. 1995. Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts. J. Infect. Dis. 172:11-18.
4. Cristensen, N. D., R. Kirnbauer, J. T. Schiller, S.-J. Ghim, R. Schlegel, A. B. Jenson, and J. W. Kreider. 1994. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology 205:329-335.
5. De Villiers, E. M., A. Schneider, H. Miklaw, U. Papendick, D. Wagner, H. Wesch, J. Wahrendorf, and H. zur Hausen. 1987. Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet ii:703-705.
6. Dillner, J., F. Wilklund, P. Lenner, C. Eklund, V. Fredriksson-Shanazarian, J. T. Schiller, M. Hibma, G. Hallmans, and U. Stendahl. 1995. Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer. Int. J. Cancer 60:377-382.
7. Dillner, J., I. Kallings, C. Brihmer, B. Sikstrom, P. Koskela, M. Lehtinen, J. T. Schiller, M. Sapp, and P. A. Mardh. 1996. Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J. Infect. Dis. 173:1394-1398.
8. Hagensee, M. E., N. Yaegashi, and D. A. Galloway. 1993. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J. Virol. 67:315-322.
9. Hagensee, M. E., N. H. Olson, T. S. Baker, and D. A. Galloway. 1994. Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids. J. Virol. 68:4503-4505.
10. Heim, K., N. D. Christensen, R. Hoepfl, B. Wartusch, G. Pinzger, A. Zeimet, P. Baumgartner, J. W. Kreider, and O. Dapunt. 1995. Serum IgG, IgM, and IgA reactivity to human papillomavirus types 11 and 6 virus-like particles in different gynecologic patient groups. J. Infect. Dis. 172:395-402.
11. Hildesheim, A., M. H. Schiffman, P. E. Gravitt, A. G. Glass, C. E. Greer, T. Zhang, D. R. Scott, B. B. Rush, P. Lawler, M. E. Sherman, R. J. Kurman, and M. M. Manos. 1994. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis. 169:235-240.
12. Hoffmann, K. J., J. C. Cook, J. G. Joyce, D. R. Brown, L. D. Schultz, H. A. George, M. Rosolowsky, K. H. Fife, and K. U. Jansen. 1995. Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae. Virology 209:506-518.
13. Kirnbauer, R., F. Booy, N. Cheng, D. R. Lowy, and J. T. Schiller. 1992. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89:12180-12184.
14. Kirnbauer, R., J. Taub, H. Greenstone, K. Roden, M. Dürst, L. Gissmann, D. R. Lowy, and J. T. Schiller. 1993. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67:6929-6936.
15. Kirnbauer, R., N. L. Hubbert, C. M. Wheeler, T. M. Becker, D. R. Lowy, and J. T. Schiller. 1994. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J. Natl. Cancer Inst. 86:494-499.
16. Kotloff, K. L., S. S. Wasserman, K. Russ, R. Daniel, S. Shapiro, W. Brown, and K. V. Shah. Lack of progressive cytological abnormalities among college women with genital human papillomavirus infection. Submitted for publication.
17. Le Cann, P., P. Coursaget, S. Iochmann, and A. Touze. 1994. Self-assembly of human papillomavirus type 16 capsids by expression of L1 protein in insect cells. FEMS Microbiol. Lett. 117:269-274.
18. Müller, M., L. Gissman, R. J. Cristiano, X.-Y. Sun, I. H. Frazer, A. B. Jenson, A. Alonso, H. Zentgraf, and J. Zhou. 1995. Papillomavirus capsid binding and uptake by cells from different tissues and species. J. Virol. 69:948-954.
19. Nonnenmacher, B., N. L. Hubbert, R. Kirnbauer, K. V. Shah, N. Munoz, F. X. Bosch, S. De Sanjose, R. Viscidi, D. R. Lowy, and J. T. Schiller. 1995. Serologic response to human papillomavirus type 16 virus-like particles in HPV 16 DNA positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. J. Infect. Dis. 172:19-24.
20. Park, D. S., L. A. Selvey, S. R. Kelsall, and I. H. Frazer. 1993. Human papillomavirus type 16 E6, E7, and L1 and type 18 E7 proteins produced by recombinant baculovirus. J. Virol. Methods 45:303-318.
21. Roden, R. B. S., N. L. Hubbert, R. Kirnbauer, N. D. Christensen, D. R. Lowy, and J. T. Schiller. 1996. Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. J. Virol. 70:3298-3301.
22. Rose, R. C., W. Bonnez, D. G. Strike, and R. C. Reichman. 1990. Expression of the full-length products of the human papillomavirus type 6b (HPV-6b) and HPV-11 L2 open reading frames by recombinant baculovirus, and antigenic comparisons with HPV-11 whole virus particles. J. Gen. Virol. 71: 2725-2729.
23. Rose, R. C., W. Bonnez, R. C. Reichman, and R. L. Garcea. 1993. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. J. Virol. 67:1936-1944.
24. Rose, R. C., R. C. Reichman, and W. Bonnez. 1994. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. J. Gen. Virol. 75:2075-2079.
25. Rose, R. C., W. Bonnez, C. Da Rin, D. J. McCance, and R. C. Reichman. 1994. Serological differentiation of human papillomavirus type 11, 16, and 18 using recombinant virus-like particles. J. Gen. Virol. 75:2445-2449.
26. Sasagawa, T., P. Pushko, R. Steers, S. E. G. Schmeissner, M. A. N. Hajibagheri, J. Finch, L. Crawford, and M. Tommasio. 1995. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virology 206:126-135.
27. Schiffman, M. H. 1994. Epidemiology of cervical papillomavirus infections, p. 55-81. In H. zur Hausen (ed.), Human pathogenic papillomaviruses. Springer Verlag, Heidelberg, Germany.
28. Viscidi, R. P., and K. V. Shah. 1992. Immune response to genital tract infections with human papillomaviruses. In T. Quinn (ed.), Sexually transmitted diseases: advances in host defense mechanisms, vol. 8. Raven Press, Ltd., New York, N.Y.
29. Volpers, C., P. Schirmacher, R. E. Streeck, and M. Sapp. 1994. Assembly of the major and minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology 200:504-512.
30. Wideroff, L., M. H. Schiffman, B. Nonnemacher, N. Hubbert, R. Kirnbauer, C. E. Greer, D. Lowy, A. T. Lorincz, M. M. Manos, A. G. Glass, D. R. Scott, M. E. Sherman, R. J. Kurman, J. Buckland, R. E. Tarone, and J. T. Schiller, 1995. Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J. Infect. Dis. 172:1425-1430.
31. Wilkstrom, A., G. J. J. van Doornum, W. G. V. Quint, J. T. Schiller, and J. Dillner. 1995. Identification of human papillomavirus seroconversions. J. Gen. Virol. 76:529-539.
32. Zhou, J., X.-Y. Sun, D. J. Stenzel, and I. H. Frazer. 1991. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 185:251-257.
33. Zhou, J., D. J. Stenzel, X.-Y. Sun, and I. H. Frazer. 1993. Synthesis and assembly of infectious bovine papillomavirus particles in vitro. J. Gen. Virol. 74:763-768.